LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 10

Search options

  1. Article ; Online: Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development.

    Agarwal, Paresh / Bertozzi, Carolyn R

    Bioconjugate chemistry

    2015  Volume 26, Issue 2, Page(s) 176–192

    Abstract: Antibody-drug conjugates (ADCs) combine the specificity of antibodies with the potency of small molecules to create targeted drugs. Despite the simplicity of this concept, generation of clinically successful ADCs has been very difficult. Over the past ... ...

    Abstract Antibody-drug conjugates (ADCs) combine the specificity of antibodies with the potency of small molecules to create targeted drugs. Despite the simplicity of this concept, generation of clinically successful ADCs has been very difficult. Over the past several decades, scientists have learned a great deal about the constraints on antibodies, linkers, and drugs as they relate to successful construction of ADCs. Once these components are in hand, most ADCs are prepared by nonspecific modification of antibody lysine or cysteine residues with drug-linker reagents, which results in heterogeneous product mixtures that cannot be further purified. With advances in the fields of bioorthogonal chemistry and protein engineering, there is growing interest in producing ADCs by site-specific conjugation to the antibody, yielding more homogeneous products that have demonstrated benefits over their heterogeneous counterparts in vivo. Here, we chronicle the development of a multitude of site-specific conjugation strategies for assembly of ADCs and provide a comprehensive account of key advances and their roots in the fields of bioorthogonal chemistry and protein engineering.
    MeSH term(s) Animals ; Chemistry Techniques, Synthetic/methods ; Drug Discovery/methods ; Glycoconjugates/chemistry ; Glycoconjugates/genetics ; Humans ; Immunoconjugates/chemistry ; Immunoconjugates/genetics ; Models, Molecular ; Protein Engineering/methods
    Chemical Substances Glycoconjugates ; Immunoconjugates
    Language English
    Publishing date 2015-02-18
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 1024041-x
    ISSN 1520-4812 ; 1043-1802
    ISSN (online) 1520-4812
    ISSN 1043-1802
    DOI 10.1021/bc5004982
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A

    Rivera-Hernandez, Tania / Carnathan, Diane G / Richter, Johanna / Marchant, Patrick / Cork, Amanda J / Elangovan, Gayathiri / Henningham, Anna / Cole, Jason N / Choudhury, Biswa / Moyle, Peter M / Toth, Istvan / Batzloff, Michael R / Good, Michael F / Agarwal, Paresh / Kapoor, Neeraj / Nizet, Victor / Silvestri, Guido / Walker, Mark J

    Vaccines

    2024  Volume 12, Issue 4

    Abstract: Vaccine development against group ... ...

    Abstract Vaccine development against group A
    Language English
    Publishing date 2024-04-04
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2703319-3
    ISSN 2076-393X
    ISSN 2076-393X
    DOI 10.3390/vaccines12040382
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Addition of Lauryldimethylamine

    Bautista, Leslie / Pill-Pepe, Lucy / Kapoor, Neeraj / Snyder, Scott / Chu, Ellen / Agarwal, Paresh / Sardar, Mohammed / Arulkumar, Shylaja / Berges, Aym / Iverson, Mark / Behrens, Christopher / Marcq, Olivier / Fairman, Jeff

    ACS omega

    2022  Volume 7, Issue 39, Page(s) 34921–34928

    Abstract: Strain-promoted azide-alkyne cycloaddition (SPAAC) reactions like click chemistry have the potential to be highly scalable, robust, and cost-effective methods for generating small- and large-molecule conjugates for a variety of applications. However, ... ...

    Abstract Strain-promoted azide-alkyne cycloaddition (SPAAC) reactions like click chemistry have the potential to be highly scalable, robust, and cost-effective methods for generating small- and large-molecule conjugates for a variety of applications. However, despite method improvements, the rates of copper-based click chemistry reactions continue to be much faster than the rates of copper-free click chemistry reactions, which makes broader deployment of click chemistry challenging from a safety and compatibility standpoint. In this study, we used a zwitterionic detergent, namely, lauryldimethylamine
    Language English
    Publishing date 2022-09-20
    Publishing country United States
    Document type Journal Article
    ISSN 2470-1343
    ISSN (online) 2470-1343
    DOI 10.1021/acsomega.2c03481
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Non-clinical immunological comparison of a Next-Generation 24-valent pneumococcal conjugate vaccine (VAX-24) using site-specific carrier protein conjugation to the current standard of care (PCV13 and PPV23)

    Fairman, Jeff / Agarwal, Paresh / Barbanel, Sandrine / Behrens, Christopher / Berges, Aym / Burky, John / Davey, Peter / Fernsten, Phil / Grainger, Chris / Guo, Sherry / Iki, Sam / Iverson, Mark / Kane, Martin / Kapoor, Neeraj / Marcq, Olivier / Migone, Thi-Sau / Sauer, Paul / Wassil, James

    Vaccine. 2021 May 27, v. 39, no. 23

    2021  

    Abstract: Despite widespread utilization of pneumococcal conjugate vaccines (PCVs) and the resultant disease reduction, the development of PCVs containing additional serotypes remains a public health priority due to serotype replacement and the resultant shift to ... ...

    Abstract Despite widespread utilization of pneumococcal conjugate vaccines (PCVs) and the resultant disease reduction, the development of PCVs containing additional serotypes remains a public health priority due to serotype replacement and the resultant shift to non-vaccine containing serotypes. However, incorporating additional serotypes to existing PCVs using conventional technologies has proven problematic. Immune responses to individual serotypes have consistently decreased as more polysaccharide-conjugates are added due to carrier suppression. Using our proprietary cell-free protein synthesis (CFPS) platform, we have successfully produced eCRM® based on the CRM₁₉₇ sequence for use as an enhanced carrier protein to develop a 24-valent PCV. The eCRM carrier protein contains multiple non-native amino acids (nnAAs) located outside of the primary T-cell epitope regions, thereby enabling site-specific covalent conjugation of the pneumococcal polysaccharides to the nnAAs to consistently expose the critical T-cell epitopes. eCRM also serves to reduce structural heterogeneity associated with classic reductive-amination conjugation while promoting formation of the conjugate matrix structures, the hallmark of PCVs. This process serves to increase the overall polysaccharide:protein ratio, enabling the inclusion of more serotypes while minimizing carrier-mediated immunological interference.The aim of this non-clinical study was to construct a 24-valent PCV and evaluate its immunogenicity. Using the XPressCF® CFPS platform, the eCRM carrier protein was separately conjugated through nnAAs to each of the 24 pneumococcal polysaccharides through click chemistry and mixed with aluminum phosphate to produce VAX-24, Vaxcyte’s proprietary PCV preclinical candidate. VAX-24, Prevnar13® and Pneumovax®23 were administered to New Zealand White rabbits to compare the resulting opsonophagocytic activity (OPA) and anti-capsular IgG antibodies. VAX-24 showed conjugate-like immune responses to all 24 serotypes based on comparable OPA and IgG responses to Prevnar13 and higher responses than Pneumovax 23. This study demonstrates the utility of site-specific conjugation technology in a preclinical setting and the potential for a PCV with improved serotype coverage.
    Keywords Streptococcus pneumoniae ; T-lymphocytes ; aluminum phosphate ; cell-free protein synthesis ; chemistry ; epitopes ; immunogenicity ; polysaccharides ; public health ; serotypes ; vaccines
    Language English
    Dates of publication 2021-0527
    Size p. 3197-3206.
    Publishing place Elsevier Ltd
    Document type Article
    Note NAL-AP-2-clean
    ZDB-ID 605674-x
    ISSN 1873-2518 ; 0264-410X
    ISSN (online) 1873-2518
    ISSN 0264-410X
    DOI 10.1016/j.vaccine.2021.03.070
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  5. Article ; Online: Systemic Fluorescence Imaging of Zebrafish Glycans with Bioorthogonal Chemistry.

    Agarwal, Paresh / Beahm, Brendan J / Shieh, Peyton / Bertozzi, Carolyn R

    Angewandte Chemie (International ed. in English)

    2015  Volume 54, Issue 39, Page(s) 11504–11510

    Abstract: Vertebrate glycans constitute a large, important, and dynamic set of post-translational modifications that are notoriously difficult to manipulate and image. Although the chemical reporter strategy has been used in conjunction with bioorthogonal ... ...

    Abstract Vertebrate glycans constitute a large, important, and dynamic set of post-translational modifications that are notoriously difficult to manipulate and image. Although the chemical reporter strategy has been used in conjunction with bioorthogonal chemistry to image the external glycosylation state of live zebrafish and detect tumor-associated glycans in mice, the ability to image glycans systemically within a live organism has remained elusive. Here, we report a method that combines the metabolic incorporation of a cyclooctyne-functionalized sialic acid derivative with a ligation reaction of a fluorogenic tetrazine, allowing for the imaging of sialylated glycoconjugates within live zebrafish embryos.
    MeSH term(s) Animals ; Glycosylation ; HEK293 Cells ; Humans ; Microscopy, Fluorescence/methods ; Polysaccharides/chemistry ; Polysaccharides/metabolism ; Zebrafish/embryology
    Chemical Substances Polysaccharides
    Language English
    Publishing date 2015-07-31
    Publishing country Germany
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2011836-3
    ISSN 1521-3773 ; 1433-7851
    ISSN (online) 1521-3773
    ISSN 1433-7851
    DOI 10.1002/anie.201504249
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Non-clinical immunological comparison of a Next-Generation 24-valent pneumococcal conjugate vaccine (VAX-24) using site-specific carrier protein conjugation to the current standard of care (PCV13 and PPV23).

    Fairman, Jeff / Agarwal, Paresh / Barbanel, Sandrine / Behrens, Christopher / Berges, Aym / Burky, John / Davey, Peter / Fernsten, Phil / Grainger, Chris / Guo, Sherry / Iki, Sam / Iverson, Mark / Kane, Martin / Kapoor, Neeraj / Marcq, Olivier / Migone, Thi-Sau / Sauer, Paul / Wassil, James

    Vaccine

    2021  Volume 39, Issue 23, Page(s) 3197–3206

    Abstract: Despite widespread utilization of pneumococcal conjugate vaccines (PCVs) and the resultant disease reduction, the development of PCVs containing additional serotypes remains a public health priority due to serotype replacement and the resultant shift to ... ...

    Abstract Despite widespread utilization of pneumococcal conjugate vaccines (PCVs) and the resultant disease reduction, the development of PCVs containing additional serotypes remains a public health priority due to serotype replacement and the resultant shift to non-vaccine containing serotypes. However, incorporating additional serotypes to existing PCVs using conventional technologies has proven problematic. Immune responses to individual serotypes have consistently decreased as more polysaccharide-conjugates are added due to carrier suppression. Using our proprietary cell-free protein synthesis (CFPS) platform, we have successfully produced eCRM® based on the CRM
    MeSH term(s) Animals ; Antibodies, Bacterial ; Carrier Proteins ; Pneumococcal Infections/prevention & control ; Pneumococcal Vaccines ; Rabbits ; Standard of Care ; Streptococcus pneumoniae ; Vaccines, Conjugate
    Chemical Substances Antibodies, Bacterial ; Carrier Proteins ; Pneumococcal Vaccines ; Vaccines, Conjugate
    Language English
    Publishing date 2021-05-06
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 605674-x
    ISSN 1873-2518 ; 0264-410X
    ISSN (online) 1873-2518
    ISSN 0264-410X
    DOI 10.1016/j.vaccine.2021.03.070
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Corneal surface glycosylation is modulated by IL-1R and

    Jolly, Amber L / Agarwal, Paresh / Metruccio, Matteo M E / Spiciarich, David R / Evans, David J / Bertozzi, Carolyn R / Fleiszig, Suzanne M J

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology

    2017  Volume 31, Issue 6, Page(s) 2393–2404

    Abstract: Cell surface glycosylation is thought to be involved in barrier function against microbes at mucosal surfaces. Previously we showed that the epithelium of healthy mouse corneas becomes vulnerable ... ...

    Abstract Cell surface glycosylation is thought to be involved in barrier function against microbes at mucosal surfaces. Previously we showed that the epithelium of healthy mouse corneas becomes vulnerable to
    MeSH term(s) Animals ; Bacterial Adhesion ; Cornea/microbiology ; Cornea/physiology ; Female ; Fibrin Tissue Adhesive ; Gene Expression Regulation/physiology ; Glycoproteins ; Glycosylation ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Myeloid Differentiation Factor 88/genetics ; Myeloid Differentiation Factor 88/metabolism ; Pseudomonas aeruginosa ; Receptors, Interleukin-1/genetics ; Receptors, Interleukin-1/metabolism
    Chemical Substances Fibrin Tissue Adhesive ; Glycoproteins ; Myd88 protein, mouse ; Myeloid Differentiation Factor 88 ; Receptors, Interleukin-1
    Language English
    Publishing date 2017-06
    Publishing country United States
    Document type Journal Article
    ZDB-ID 639186-2
    ISSN 1530-6860 ; 0892-6638
    ISSN (online) 1530-6860
    ISSN 0892-6638
    DOI 10.1096/fj.201601198R
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: A Pictet-Spengler ligation for protein chemical modification.

    Agarwal, Paresh / van der Weijden, Joep / Sletten, Ellen M / Rabuka, David / Bertozzi, Carolyn R

    Proceedings of the National Academy of Sciences of the United States of America

    2012  Volume 110, Issue 1, Page(s) 46–51

    Abstract: Aldehyde- and ketone-functionalized proteins are appealing substrates for the development of chemically modified biotherapeutics and protein-based materials. Their reactive carbonyl groups are typically conjugated with α-effect nucleophiles, such as ... ...

    Abstract Aldehyde- and ketone-functionalized proteins are appealing substrates for the development of chemically modified biotherapeutics and protein-based materials. Their reactive carbonyl groups are typically conjugated with α-effect nucleophiles, such as substituted hydrazines and alkoxyamines, to generate hydrazones and oximes, respectively. However, the resulting C=N linkages are susceptible to hydrolysis under physiologically relevant conditions, which limits the utility of such conjugates in biological systems. Here we introduce a Pictet-Spengler ligation that is based on the classic Pictet-Spengler reaction of aldehydes and tryptamine nucleophiles. The ligation exploits the bioorthogonal reaction of aldehydes and alkoxyamines to form an intermediate oxyiminium ion; this intermediate undergoes intramolecular C-C bond formation with an indole nucleophile to form an oxacarboline product that is hydrolytically stable. We used the reaction for site-specific chemical modification of glyoxyl- and formylglycine-functionalized proteins, including an aldehyde-tagged variant of the therapeutic monoclonal antibody Herceptin. In conjunction with techniques for site-specific introduction of aldehydes into proteins, the Pictet-Spengler ligation offers a means to generate stable bioconjugates for medical and materials applications.
    MeSH term(s) Aldehydes/chemistry ; Antibodies, Monoclonal, Humanized/chemistry ; Bioengineering/methods ; Biological Therapy/methods ; Ketones/chemistry ; Magnetic Resonance Spectroscopy ; Molecular Structure ; Proteins/chemistry ; Trastuzumab ; Tryptamines/chemistry
    Chemical Substances Aldehydes ; Antibodies, Monoclonal, Humanized ; Ketones ; Proteins ; Tryptamines ; Trastuzumab (P188ANX8CK)
    Language English
    Publishing date 2012-12-13
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.1213186110
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Hydrazino-Pictet-Spengler ligation as a biocompatible method for the generation of stable protein conjugates.

    Agarwal, Paresh / Kudirka, Romas / Albers, Aaron E / Barfield, Robyn M / de Hart, Gregory W / Drake, Penelope M / Jones, Lesley C / Rabuka, David

    Bioconjugate chemistry

    2013  Volume 24, Issue 6, Page(s) 846–851

    Abstract: Aldehyde- and ketone-functionalized biomolecules have found widespread use in biochemical and biotechnological fields. They are typically conjugated with hydrazide or aminooxy nucleophiles under acidic conditions to yield hydrazone or oxime products that ...

    Abstract Aldehyde- and ketone-functionalized biomolecules have found widespread use in biochemical and biotechnological fields. They are typically conjugated with hydrazide or aminooxy nucleophiles under acidic conditions to yield hydrazone or oxime products that are relatively stable, but susceptible to hydrolysis over time. We introduce a new reaction, the hydrazino-Pictet-Spengler (HIPS) ligation, which has two distinct advantages over hydrazone and oxime ligations. First, the HIPS ligation proceeds quickly near neutral pH, allowing for one-step labeling of aldehyde-functionalized proteins under mild conditions. Second, the HIPS ligation product is very stable (>5 days) in human plasma relative to an oxime-linked conjugate (∼1 day), as demonstrated by monitoring protein-fluorophore conjugates by ELISA. Thus, the HIPS ligation exhibits a combination of product stability and speed near neutral pH that is unparalleled by current carbonyl bioconjugation chemistries.
    MeSH term(s) Aldehydes/chemistry ; Biocompatible Materials/chemistry ; Humans ; Hydrazines/chemistry ; Hydrogen-Ion Concentration ; Hydrolysis ; Ketones/chemistry ; Models, Molecular ; Molecular Structure ; Oximes/chemistry ; Proteins/chemistry
    Chemical Substances Aldehydes ; Biocompatible Materials ; Hydrazines ; Ketones ; Oximes ; Proteins ; hydrazine (27RFH0GB4R)
    Language English
    Publishing date 2013-06-19
    Publishing country United States
    Document type Journal Article ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 1024041-x
    ISSN 1520-4812 ; 1043-1802
    ISSN (online) 1520-4812
    ISSN 1043-1802
    DOI 10.1021/bc400042a
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: An isolable and monomeric phosphorus radical that is resonance-stabilized by the vanadium(IV/V) redox couple.

    Agarwal, Paresh / Piro, Nicholas A / Meyer, Karsten / Müller, Peter / Cummins, Christopher C

    Angewandte Chemie (International ed. in English)

    2007  Volume 46, Issue 17, Page(s) 3111–3114

    Language English
    Publishing date 2007
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 2011836-3
    ISSN 1521-3773 ; 1433-7851
    ISSN (online) 1521-3773
    ISSN 1433-7851
    DOI 10.1002/anie.200700059
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top